Executive-CSV

Jubilant Pharma Limited is a global integrated pharmaceutical company offering a wide range of products and services to customers across geographies. The business is organized into two segments - Specialty Pharmaceuticals and Generics & APIs. Jubilant Generics (JGL), a wholly-owned subsidiary of Jubilant Pharma, has Research & Development units in Noida and Mysore, India. JGL operates two manufacturing facilities in Mysore, Karnataka, and Roorkee, Uttarakhand, specializing in APIs and Dosage manufacturing. The Mysore manufacturing location, spread over 69 acres, is a USFDA approved site focusing on Lifestyle driven Therapeutic Areas such as CVS and CNS. It is a market leader in four APIs and amongst the top three players for three others. The Roorkee facility is a state-of-the-art site approved by USFDA, Japan PMDA, UK MHRA, TGA, WHO, and Brazil ANVISA, following a B2B model for EU, Canada, and emerging markets. Both manufacturing units are supported by around 500 research and development professionals based in Noida and Mysore. The R&D team works on developing new products in API, Solid Dosage Formulations of Oral Solid, Sterile Injectable, Semi-Solids Ointments, Creams, and Liquids. In-house BA/BE studies are conducted at an 80 Bed facility with multiple global regulatory accreditations. JGL's Regulatory Affairs & IPR professionals maintain a unique portfolio of patents and product filings in regulatory and non-regulatory markets. The revenue of Jubilant Pharma has been on a consistent rise, reaching INR 53,240 Million during the Financial Year 2018-19 compared to INR 39,950 Million in 2017-18. For more information about the organization, please visit www.jubilantpharma.com.,